Highlights • Chronic liver disease (CLD) patients exhibit good immune responses to booster inactivated SARS-CoV-2 vaccine. • Omicron BA.4/5 can evade the immune response elicited by the booster shot. • HBsAg levels positively correlate with neutralizing antibodies and anti-RBD IgG. • Decreased levels of B and NK cells may explain lowered antibodies in CLD patients.
All Keywords
【저자키워드】 immune response, Antibody Response, SARS-CoV-2 inactivated vaccines, booster vaccination, Chronic liver disease (CLD),
【저자키워드】 immune response, Antibody Response, SARS-CoV-2 inactivated vaccines, booster vaccination, Chronic liver disease (CLD),